LY3074828

· Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for LY3074828, covering 2018-03-29 to 2024-02-20. Get the full timeline:

Most recent: Clinical Trial Update: A Study of LY3074828 in Healthy Participants [Phase 1]